Business
Ikonisys SA: Suspension of Trading of Shares on Euronext Growth Paris Until the Publication of the 2024 Annual Report
PARIS, July 01, 2025--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, today announces the suspension of the trading of its shares on Euronext Growth Paris. It will resume as soon as the company publishes its 2024 annual report.
About this update from Ikonisys Sa
[{"type":"text","content":"PARIS, July 01, 2025--(BUSINESS WIRE)--Regulatory News:","length":55,"tagName":"p"},{"type":"text","content":"Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, today announces the suspension of the trading of its shares on Euronext Growth Paris. It will resume as soon as the company publishes its 2024 annual report.","length":349,"tagName":"p"},{"type":"text","content":"The publication of the 2024 annual financial report had been postponed to June 30, 2025, and due to its unavailability as of today, Euronext suspended trading of the Company’s shares on July 1st, 2025.","length":201,"tagName":"p"},{"type":"text","content":"This delay is primarily due to additional technical delays related to the full consolidation of the Ikonisys Group with Hospitex for the first time, including the purchase price allocation (PPA) of Hospitex's assets, a complex accounting process that required more time and coordination than initially expected.","length":315,"tagName":"p"},{"type":"text","content":"The Group is actively working with its statutory auditors and internal teams to finalize the report as quickly as possible and ensure the highest level of accuracy and transparency, with a view to resuming the trading of IKONISYS shares on Euronext Growth Paris.","length":262,"tagName":"p"},{"type":"text","content":"-----------------------","length":23,"tagName":"p"},{"type":"text","content":"About ALIKO SCIENTIFIC (Ikonisys SA)Headquartered in Paris, ALIKO SCIENTIFIC is the parent company of an international ecosystem of businesses dedicated to advancing oncology diagnostics. Listed on Euronext Growth Paris under the ticker ALIKO, the company coordinates industrial, financial and research activities through its subsidiaries: Ikonisys Inc. (USA) and Hospitex International (Italy). ALIKO SCIENTIFIC's mission is to innovate cancer diagnosis by uniting cutting-edge technologies, resources, and strategic investments to create a global center of excellence in oncology.","length":587,"tagName":"p"},{"type":"text","content":"For more information, visit: www.alikoscientific.com","length":52,"tagName":"p"},{"type":"text","content":"About IKONISYSIkonisys is a global leader in automated diagnostics, specializing i...